Oncol Rep 32: [Related article:] 205–212, 2014; DOI:
10.3892/or.2014.3201
Following the publication of the above article and a
corrigendum (doi: 10.3892/or.2017.5455) that was issued in 2017 to
address issues of incorrect data assembly in Figs. 3 and 7, an
interested reader drew to our attention that data also appeared to
be duplicated in Fig. 4C, and data featured in Figs. 2 and 5
subsequently appeared in an article published by the same research
group in the journal Oncotarget. Additionally, following an
independent re-evaluation of the data in this paper made by the
Editorial Office, duplicated data were also noted in Fig. 5A, and
some of the data in question subsequently appeared in an article in
Journal of Enzyme Inhibition and Medicinal Chemistry in 2022
written by different authors at different institutes, which has
since been retracted.
In view of these additional findings, even though
the possibility of a further corrigendum was originally considered,
the Editor of Oncology Reports has decided that the paper
should be retracted on account of a lack of confidence in the
presented data. The authors were asked for an explanation to
account for these concerns, but the Editorial Office did not
receive a satisfactory reply. The Editor apologizes to the
readrship for any inconvenience caused.
